You are not currently logged in.
Access JSTOR through your library or other institution:
Understanding disparities in leukemia: a national study
M. I. Patel, Y. Ma, B. S. Mitchell and K. F. Rhoads
Cancer Causes & Control
Vol. 23, No. 11 (November 2012), pp. 1831-1837
Published by: Springer
Stable URL: http://www.jstor.org/stable/23274505
Page Count: 7
You can always find the topics here!Topics: Myeloid leukemia, Leukemia, Hispanics, Prophets, Mortality, Health outcomes, Children, Referents, Epidemiology, Genetic mutation
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
Preview not available
Purpose: Disparities in solid tumors have been well studied. However, disparities in hematologic malignancies have been relatively unexplored on population-based levels. The purpose of this study is to examine the relationship between race/ethnicity and acute leukemia mortality. Methods: All patients with acute leukemia [acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML)] were identified in the Surveillance Epidemiology and End Results database, 1999—2008. Kaplan—Meier curves were generated to reflect survival probabilities by race/ethnicity. Multivariable Cox proportional hazard models estimated hazard of mortality by race with adjustment for individual (age, gender, year of diagnosis) and select genetic factors. Results: A total of 39,002 patients with acute leukemia were included in the study. Overall, there was a mortality disparity in acute leukemia for blacks (HR 1.17, p < 0.0001) and Hispanics (HR 1.13, p < 0.0001) compared with non-Hispanic whites. In stratified analysis, disparities in ALL were greater than AML; blacks (HR[ALL]1.45, p < 0.0001; HR[AML]1.12, p < 0.0011); Hispanics (HR[ALL]1.46, p < 0.0001; HR[AML]1.06, p < 0.0001). Adjustment for individual patient and select genetic factors did not explain disparities. Conclusions: Blacks and Hispanics suffer decreased survival in acute leukemia as compared to others. Further investigation is needed to understand the drivers of poor cancer outcomes in these populations.
Cancer Causes & Control © 2012 Springer